Established in September 1993, Aimei Hissen Vaccine (Dalian) Co., Ltd was one of the earliest high-tech bio-pharmaceutical enterprises engaged in R&D, production and sales of vaccine in China. Aimei Hissen has a registered capital of 160 million RMB. And, it is one of the earliest enterprises with provincial level technology development center.......